Abstract

Dihydroresveratrol is a metabolite of trans-resveratrol formed in the intestine by the hydrogenation of the double bond by microflora. The aim of the present study was to validate a method to measure dihydroresveratrol in rat plasma and then to quantify its plasmatic concentration after the oral administration of 60 mg/kg to Sprague-Dawley rats. Dihydroresveratrol was extracted from acidified plasma with a C18 cartridge, eluted with methanol, and concentrated prior to HPLC analysis with diode-array detection (HPLC-DAD) at 276 nm. The method was validated by spiking blank plasma samples with pure dihydroresveratrol, obtaining a linear correlation and good interday and intraday precisions, expressed as coefficient of variation (<7%). The average recovery was 96.7% and the limit of detection was 275 nM. The oral administration of dihydroresveratrol to rats and its subsequent detection, along with dihydroresveratrol glucuronide and sulfate, provides evidence of its absorption and metabolism.